Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients

NCT03220256 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lamotrigine Allergy

Interventions

DRUG: Lamotrigine

Sponsor

Seoul National University Hospital